top of page

Kromek Awarded Funding for £2.5m Breast Cancer Screening Solution Developments

NETPark based Kromek (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces that it has been awarded funding from the UK’s innovation agency, Innovate UK, for two research programmes to further develop a low-dose molecular breast imaging (“MBI”) technology based on Kromek’s CZT-based SPECT detectors.

The first project is designed to prove the feasibility of using a single photon detector for ultra-low-dose MBI. This 18-month project, worth £0.5m, is to be carried out solely by Kromek. The second project, worth £2.0m, is a three-year programme to obtain and deliver clinical data on a low-dose MBI system. It is being conducted in partnership with Newcastle-upon-Tyne Hospitals NHS Foundation Trust (“Newcastle Hospitals”), the University of Newcastle-upon-Tyne and University College London.

تعليقات


Other Business News

Business Durham

Catch up with the latest regional business news

Add Your News

At Business Durham, we believe that sharing positive news stories about successful businesses in County Durham is important for fostering a supportive and thriving business community. We want to encourage business owners to send us their success stories so that we can share them on our website and celebrate their achievements. We are committed to promoting the county as a great place to do business and providing a platform for businesses to showcase their successes.

Contact us today to share your story!